# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MK-7246 | 5, Merck | Ki | = | 3804 | nM | ALA5214285 | 5.42 | nM | Homo sapiens | ||
2. | ALA1643772 | 7 | Ki | = | 6489 | nM | ALA5214315 | 5.19 | nM | Homo sapiens | ||
3. | Pemigatinib | PEMIGATINIB | INH | 0 | ALA4810225 | Not Active | % | Homo sapiens | ||||
4. | ALA4446093 | 34 | Activity | = | 5.9 | % | ALA4337227 | % | Homo sapiens | |||
5. | ALA4470517 | 33 | Activity | = | 5.6 | % | ALA4337227 | % | Homo sapiens | |||
6. | Belzutifan | 2; PT2977 | Activity | 0 | ALA4312690 | Not Active | Homo sapiens | |||||
7. | GSK726701A | 30; GSK726701A | pIC50 | < | 5 | ALA4223525 | nM | Homo sapiens | ||||
8. | S-(-)-Cotinine | cotinine | INH | < | 50 | % | ALA4676916 | % | Homo sapiens | |||
9. | ALA4779424 | Metanicotine | IC50 | > | 10 | uM | ALA4676891 | nM | Homo sapiens | |||
10. | BAY-6672 | EUB0001111 | IC50 | = | 2.2 | uM | ALA4671540 | 5.66 | nM | Homo sapiens | ||
11. | PF 04418948 | 15, PF-04418948 | Ki | > | 10 | uM | ALA4886927 | Not Active | nM | Homo sapiens | ||
12. | PF 04418948 | 15, PF-04418948 | % inhibition | 0 | % | ALA4887043 | Not Active | % | Homo sapiens | |||
13. | BAY-6672 | EUB0001111 | IC50 | 2.21 | uM | ALA4885645 | Not Active | nM | Homo sapiens | |||
14. | ALA3480577 | DDD01251909 | Mean fold stimulation | 0.125 | ALA4883613 | Homo sapiens | ||||||
15. | ALA1643772 | 7 | Ki | > | 6489 | nM | ALA4882632 | Not Active | nM | Homo sapiens | ||
16. | MK-7246 | 5, Merck | Ki | 3804 | nM | ALA4882632 | Not Active | nM | Homo sapiens | |||
17. | BI-1935 | EUB0000542 | % Ctrl | 98 | % | ALA4882538 | Not Active | % | Homo sapiens | |||
18. | ABT 724 | 3a | % inhibition | < | 10 | % | ALA4880373 | Not Active | % | Homo sapiens | ||
19. | ALA111612 | 10a | % inhibition | 16 | % | ALA4880288 | Not Active | % | Homo sapiens | |||
20. | ABT-100 | EUB0000289 | % inhibition | 24 | % | ALA4880212 | Not Active | % | Homo sapiens |